G Paul Amminger

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. doi request reprint The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission
    Lisa P Henry
    ORYGEN Research Centre, Locked Bag 10, Parkville, Melbourne, Victoria, 3052, Australia
    J Clin Psychiatry 71:716-28. 2010
  2. ncbi request reprint Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Can J Psychiatry 58:402-8. 2013
  3. doi request reprint Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study
    G Paul Amminger
    Orygen Youth Health Centre for Youth Mental Health, 35 Poplar Road, Parkville, VIC 3052, Australia
    Schizophr Res 131:112-9. 2011
  4. pmc Emotion recognition in individuals at clinical high-risk for schizophrenia
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Wahringer Gurtel, Austria
    Schizophr Bull 38:1030-9. 2012
  5. doi request reprint Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Early Interv Psychiatry 6:450-4. 2012
  6. ncbi request reprint Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
    Gregor E Berger
    Orygen Youth Health Research Centre, Locked Bag 10, Parkville, Victoria, 3052, Australia
    Curr Pharm Des 18:570-5. 2012
  7. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
    Monika Schlögelhofer
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Vienna, Austria Division of Biological Psychiatry, Medical University Vienna, Vienna, Austria
    Early Interv Psychiatry 8:199-208. 2014
  8. doi request reprint Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Waehringer Guertel 18 10, 1090 Vienna, Austria
    Schizophr Res 148:163-7. 2013
  9. doi request reprint The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Schizophr Res 141:210-4. 2012
  10. ncbi request reprint Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis
    Suzie Lavoie
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, The University of Melbourne and Melbourne Health, 35 Poplar Road, Parkville 3052, Australia
    Schizophr Res 138:206-11. 2012

Detail Information

Publications22

  1. doi request reprint The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission
    Lisa P Henry
    ORYGEN Research Centre, Locked Bag 10, Parkville, Melbourne, Victoria, 3052, Australia
    J Clin Psychiatry 71:716-28. 2010
    ..To describe the longer-term clinical and functional outcome of a large, epidemiologic representative cohort of individuals experiencing a first episode of psychosis...
  2. ncbi request reprint Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Can J Psychiatry 58:402-8. 2013
    ....
  3. doi request reprint Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study
    G Paul Amminger
    Orygen Youth Health Centre for Youth Mental Health, 35 Poplar Road, Parkville, VIC 3052, Australia
    Schizophr Res 131:112-9. 2011
    ..To compare the long-term outcome in individuals with early-onset (before age 18) and adult-onset schizophrenia spectrum disorder who were initially diagnosed and treated in the same clinical center...
  4. pmc Emotion recognition in individuals at clinical high-risk for schizophrenia
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Wahringer Gurtel, Austria
    Schizophr Bull 38:1030-9. 2012
    ..The results suggest a trait deficit and an involvement of the amygdala in the pathology of ultra high-risk states...
  5. doi request reprint Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Early Interv Psychiatry 6:450-4. 2012
    ..The study aims to investigate affect recognition in young people at different stages of psychotic illness...
  6. ncbi request reprint Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
    Gregor E Berger
    Orygen Youth Health Research Centre, Locked Bag 10, Parkville, Victoria, 3052, Australia
    Curr Pharm Des 18:570-5. 2012
    ..To investigate if low-dose lithium may counteract the microstructural and metabolic brain changes proposed to occur in individuals at ultra-high risk (UHR) for psychosis...
  7. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
    Monika Schlögelhofer
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Vienna, Austria Division of Biological Psychiatry, Medical University Vienna, Vienna, Austria
    Early Interv Psychiatry 8:199-208. 2014
    ..Considering the rising interest in omega-3 PUFA supplementation as preventive treatment strategy in young people at risk of psychosis, the question of safety issues must be addressed...
  8. doi request reprint Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Waehringer Guertel 18 10, 1090 Vienna, Austria
    Schizophr Res 148:163-7. 2013
    ..The delay of onset of ω -3 PUFAs seems comparable to that of antipsychotics and antidepressants. ..
  9. doi request reprint The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Schizophr Res 141:210-4. 2012
    ..It may represent a useful screening tool for calling clinicians' attention to subjects with psychotic-like experiences...
  10. ncbi request reprint Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis
    Suzie Lavoie
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, The University of Melbourne and Melbourne Health, 35 Poplar Road, Parkville 3052, Australia
    Schizophr Res 138:206-11. 2012
    ..The results suggest that decreased frontal delta activity, in combination with high levels of negative symptoms, may be a risk factor for subsequent transition to psychosis in UHR individuals...
  11. doi request reprint Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?
    Barnaby Nelson
    ORYGEN Research Centre, University of Melbourne, Parkville, Victoria, Australia
    Early Interv Psychiatry 3:83-93. 2009
    ..This paper attempts to integrate a strand of cognitive research in psychotic disorders (specifically, social cognition research) with phenomenological accounts of schizophrenia and other psychotic disorders...
  12. ncbi request reprint Duration of untreated psychosis in a high-income versus a low- and middle-income region
    Nilufar Mossaheb
    1Department of Psychiatry and Psychotherapy, Division of Social Psychiatry, Medical University of Vienna, Vienna, Austria
    Aust N Z J Psychiatry 47:1176-82. 2013
    ..The aim of this study was to compare DUP in a high-income country with that in a LAMI country using the same methodology...
  13. doi request reprint Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
    G Paul Amminger
    Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria
    Arch Gen Psychiatry 67:146-54. 2010
    ..Given that omega-3 PUFAs are generally beneficial to health and without clinically relevant adverse effects, their preventive use in psychosis merits investigation...
  14. doi request reprint Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
    J Clin Psychiatry 74:349-56. 2013
    ..The aim of this study was to determine which intervention was most effective at preventing transition to psychosis: cognitive therapy plus low-dose risperidone, cognitive therapy plus placebo, or supportive therapy plus placebo...
  15. ncbi request reprint PACE: a specialised service for young people at risk of psychotic disorders
    Alison R Yung
    PACE Clinic, ORYGEN Youth Health, Melbourne, Vic, Australia
    Med J Aust 187:S43-6. 2007
    ....
  16. ncbi request reprint Bioactive lipids in schizophrenia
    Gregor E Berger
    ORYGEN Youth Health and ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
    Int Rev Psychiatry 18:85-98. 2006
    ..This review investigates the role of bioactive lipids in schizophrenia and its treatment, as well as its potential use in prevention...
  17. doi request reprint Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis
    Alison R Yung
    ORYGEN Research Centre and University of Melbourne, Department of Psychiatry, 35 Poplar Rd, Parkville 3052, Victoria, Australia
    J Clin Psychiatry 72:430-40. 2011
    ..However, it is unclear which of these treatments are most effective, how long treatment should be given, and whether effects will be sustained over a prolonged period...
  18. doi request reprint Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care
    Patrick D McGorry
    Orygen Youth Health Research Centre, Centre for Youth Mental Health, Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
    Curr Opin Psychiatry 24:301-6. 2011
    ..To provide an update of the recent studies on the age of onset of the major mental illnesses, with a special focus on the prospects for prevention and early intervention...
  19. doi request reprint Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristics
    Lisa P Henry
    ORYGEN Research Centre, University of Melbourne, Melbourne, Victoria, Australia
    Early Interv Psychiatry 1:49-60. 2007
    ..This paper reports the rationale, methodology and baseline characteristics of a large long-term follow-up study of first-episode psychosis from a geographically defined catchment area...
  20. ncbi request reprint Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics
    Brian O'Donoghue
    The Early Psychosis Prevention and Intervention Centre EPPIC, ORYGEN Youth Health, Parkville, Victoria, Australia
    Early Interv Psychiatry 8:276-80. 2014
    ..This study aimed to investigate the metabolic side effects of SGAs, specifically olanzapine, risperidone and quetiapine, in a cohort of drug-naïve children and adolescents with first-episode EOS...
  21. ncbi request reprint Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study
    Gregor E Berger
    Department of Psychiatry, ORYGEN Research Centre, University of Melbourne, Parkville, Australia
    Neuropsychopharmacology 33:2467-73. 2008
    ..Larger confirmatory studies of these postulated metabolic brain effects of E-EPA are warranted...
  22. ncbi request reprint Polyunsaturated fatty acids in emerging psychosis
    Nilufar Mossaheb
    Department of Child and Adolescent Psychiatry, Medical University Vienna, Austria
    Curr Pharm Des 18:576-91. 2012
    ..The neuroprotective potential of n-3 LC-PUFAs for indicated prevention, i.e. delaying transition to psychosis in high-risk populations needs to be further explored...